<H1>Chapter DOI: 10.1007/978-1-60327-527-9_6<br/>Cited-By Count: 0</H1><table border="1" width="30%"><tr><td>Total References</td><td>36</td></tr><tr><td>Springer references</td><td>1</td></tr><tr><td>Non Springer references</td><td>35</td></tr><tr><td>BibStructured Count</td><td width="10%">35</td></tr><tr><td>BibUnstructured Count</td><td width="10%">1</td></tr><tr><td>DOI already available in SpringerLink</td><td>24</td></tr><tr><td>Additional DOI extracted from CrossRef-Meta</td><td>4</td></tr><tr><td>Additional DOI extracted from CrossRef-Web</td><td>0</td></tr><tr><td>Additional DOI extracted from ResearchGate-Web</td><td>0</td></tr><tr><td>Additional DOI extracted from SpringerLink-FUZZY-Search</td><td>0</td></tr><tr><td>Spelling Mistakes</td><td>NULL</td></tr><tr><td>Wrong DOI</td><td>0</td></tr><tr><td>ISBN</td><td>NULL</td></tr><tr><td>Web Link</td><td>NULL</td></tr><tr><td>DOI Obtained For Springer Published</td><td>0</td></tr><tr><td>DOI Obtained For Non Springer</td><td>4</td></tr><tr><td>DOI Obtained From Structured Ref</td><td>3</td></tr><tr><td>DOI Obtained From Unstructured Ref</td><td>1</td></tr><tr><td>Valid DOI Enriched</td><td>4</td></tr></table></br></br><table border="1">
<tr><th>Bib. ID</th><th>Ref. Type</th><th>References</th><th>DOI</th><th>Suspected DOI</th><th>DOI Source</th><th>Validated Elements</th><th>Validation Source</th></tr><tr><td>CR1</td><td>BibArticle</td><td>Lanzavecchia A, Sallusto F. Dynamics of T lymphocyte responses: intermediates, effectors, and memory cells. Science 2000;290:92&#8211;7.</td><td><a href=http://dx.doi.org/10.1126/science.290.5489.92>10.1126/science.290.5489.92</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR2</td><td>BibArticle</td><td>Lanzavecchia A. Understanding the mechanisms of sustained signaling and T cell activation. J Exp Med 1997;185:1717&#8211;9.</td><td><a href=http://dx.doi.org/10.1084/jem.185.10.1717>10.1084/jem.185.10.1717</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR3</td><td>BibArticle</td><td>Colombetti S, Basso V, Mueller DL, Mondino A. Prolonged TCR/CD28 engagement drives IL-2-independent T cell clonal expansion through signaling mediated by the mammalian target of rapamycin. J Immunol 2006;176:2730&#8211;8.</td><td><a href=http://dx.doi.org/10.4049/jimmunol.176.5.2730>10.4049/jimmunol.176.5.2730</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>Author_FamilyName_1, ArticleTitle, Author_FamilyName_2, VolumeID, FirstPage, Year</td><td>CrossRef</td></tr><tr><td>CR4</td><td>BibArticle</td><td>Saha K, Volsky DJ, Matczak E. Resistance against syncytium-inducing human immunodeficiency virus type 1 (HIV-1) in selected CD4(+) T cells from an HIV-1-infected nonprogressor: evidence of a novel pathway of resistance mediated by a soluble factor(s) that acts after virus entry. J Virol 1999;73:7891&#8211;8.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR5</td><td>BibArticle</td><td>Maynard J, Petersson K, Wilson DH, et al. Structure of an autoimmune T cell receptor complexed with class II peptide-MHC: insights into MHC bias and antigen specificity. Immunity 2005;22:81&#8211;92.</td><td><a href=http://dx.doi.org/10.1016/j.immuni.2004.11.015>10.1016/j.immuni.2004.11.015</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>Author_FamilyName_1, ArticleTitle, Author_FamilyName_2, JournalTitle, VolumeID, FirstPage, Year</td><td>CrossRef</td></tr><tr><td>CR6</td><td>BibArticle</td><td>Artini M, Nisini R, Missale G, et al. Infection of circulating and liver infiltrating T cells by hepatitis C virus of different subtypes. Viral Immunol 1995;8:63&#8211;73.</td><td><a href=http://dx.doi.org/10.1089/vim.1995.8.63>10.1089/vim.1995.8.63</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR7</td><td>BibArticle</td><td>Kelso A, Groves P, Troutt AB, Francis K. Evidence for the stochastic acquisition of cytokine profile by CD4+ T cells activated in a T helper type 2-like response in vivo. Eur J Immunol 1995;25:1168&#8211;75.</td><td><a href=http://dx.doi.org/10.1002/eji.1830250506>10.1002/eji.1830250506</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR8</td><td>BibArticle</td><td>Demotz S, Lanzavecchia A, Eisel U, Niemann H, Widmann C, Corradin G. Delineation of several DR-restricted tetanus toxin T cell epitopes. J Immunol 1989;142:394&#8211;402.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR9</td><td>BibArticle</td><td>Lanzavecchia A, Santini P, Maggi E, et al. In vitro selective expansion of allergen specific T cells from atopic patients. Clin Exp Immunol 1983;52:21&#8211;8.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR10</td><td>BibArticle</td><td>Romagnani S, Maggi E, Parronchi P, Macchia D, Piccinni MP, Ricci M. Increased numbers of Th2-like CD4+ T cells in target organs and in the allergen-specific repertoire of allergic patients. Possible role of IL-4 produced by non-T cells. Int Arch Allergy Appl Immunol 1991;94:133&#8211;6.</td><td><a href=http://dx.doi.org/10.1159/000235344>10.1159/000235344</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR11</td><td>BibArticle</td><td>Nikolova M, Echchakir H, Wechsler J, Boumsell L, Bensussan A, Bagot M. Isolation of a CD8alphaalpha+ CD4- tumour T-cell clone with cytotoxic activity from a CD4+ CD8- cutaneous T-cell lymphoma. Br J Dermatol 2003;148:24&#8211;9.</td><td><a href=http://dx.doi.org/10.1046/j.1365-2133.2003.05015.x>10.1046/j.1365-2133.2003.05015.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR12</td><td>BibArticle</td><td>Sobel DO, Creswell K. Characterization of anti-islet cytotoxic human T-cell clones from patients with type 1 diabetes mellitus. Autoimmunity 2006;39:323&#8211;32.</td><td><a href=http://dx.doi.org/10.1080/08916930600720753>10.1080/08916930600720753</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR13</td><td>BibArticle</td><td>Franco A, Barnaba V, Ruberti G, Benvenuto R, Balsano C, Musca A. Liver-derived T cell clones in autoimmune chronic active hepatitis: accessory cell function of hepatocytes expressing class II major histocompatibility complex molecules. Clin Immunol Immunopathol 1990;54:382&#8211;94.</td><td><a href=http://dx.doi.org/10.1016/0090-1229(90)90052-R>10.1016/0090-1229(90)90052-R</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR14</td><td>BibArticle</td><td>Wang RF, Appella E, Kawakami Y, Kang X, Rosenberg SA. Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes. J Exp Med 1996;184:2207&#8211;16.</td><td><a href=http://dx.doi.org/10.1084/jem.184.6.2207>10.1084/jem.184.6.2207</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR15</td><td>BibArticle</td><td>Gervois N, Guilloux Y, Diez E, Jotereau F. Suboptimal activation of melanoma infiltrating lymphocytes (TIL) due to low avidity of TCR/MHC-tumor peptide interactions. J Exp Med 1996;183:2403&#8211;7.</td><td><a href=http://dx.doi.org/10.1084/jem.183.5.2403>10.1084/jem.183.5.2403</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR16</td><td>BibArticle</td><td>Nisini R, Paroli M, Accapezzato D, et al. Human CD4+ T-cell response to hepatitis delta virus: identification of multiple epitopes and characterization of T-helper cytokine profiles. J Virol 1997;71:2241&#8211;51.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR17</td><td>BibArticle</td><td>Unutmaz D, Pileri P, Abrignani S. Antigen-independent activation of naive and memory resting T cells by a cytokine combination. J Exp Med 1994;180:1159&#8211;64.</td><td><a href=http://dx.doi.org/10.1084/jem.180.3.1159>10.1084/jem.180.3.1159</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR18</td><td>BibArticle</td><td>Morley AA, Trainor KJ, Seshadri RS. Cloning of human lymphocytes using limiting dilution. Exp Hematol 1983;11:418&#8211;24.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR19</td><td>BibArticle</td><td>Sharrock CE, Kaminski E, Man S. Limiting dilution analysis of human T cells: a useful clinical tool. Immunol Today 1990;11:281&#8211;6.</td><td><a href=http://dx.doi.org/10.1016/0167-5699(90)90113-N>10.1016/0167-5699(90)90113-N</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR20</td><td>BibArticle</td><td>Nisini R, Fattorossi A, Ferlini C, D'Amelio R. One cause for the apparent inability of human T cell clones to function as professional superantigen-presenting cells is autoactivation. Eur J Immunol 1996;26:797&#8211;803.</td><td><a href=http://dx.doi.org/10.1002/eji.1830260411>10.1002/eji.1830260411</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR21</td><td>BibArticle</td><td>Nisini R, Matricardi PM, Fattorossi A, Biselli R, D'Amelio R. Presentation of superantigen by human T cell clones: a model of T-T cell interaction. Eur J Immunol 1992;22:2033&#8211;9.</td><td><a href=http://dx.doi.org/10.1002/eji.1830220812>10.1002/eji.1830220812</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR22</td><td>BibArticle</td><td>Nisini R, Romagnoli G, Gomez MJ, et al. Antigenic properties and processing requirements of 65-kilodalton mannoprotein, a major antigen target of anti-Candida human T-cell response, as disclosed by specific human T-cell clones. Infect Immun 2001;69:3728&#8211;36.</td><td><a href=http://dx.doi.org/10.1128/IAI.69.6.3728-3736.2001>10.1128/IAI.69.6.3728-3736.2001</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR23</td><td>BibArticle</td><td>Bonnefoix T, Bonnefoix P, Mi JQ, Lawrence JJ, Sotto JJ, Leroux D. Detection of suppressor T lymphocytes and estimation of their frequency in limiting dilution assays by generalized linear regression modeling. J Immunol 2003;170:2884&#8211;94.</td><td><a href=http://dx.doi.org/10.4049/jimmunol.170.6.2884>10.4049/jimmunol.170.6.2884</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>Author_FamilyName_2, VolumeID, Year, FirstPage, Author_FamilyName_1, ArticleTitle</td><td>CrossRef</td></tr><tr><td>CR24</td><td>BibArticle</td><td>Waldmann H, Pope H, Lefkovits I. Limiting dilution analysis of helper T-cell function. II. An approach to the study of the function of single helper T cells. Immunology 1976;31:343&#8211;52.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR25</td><td>BibArticle</td><td>Waldmann H, Lefkovits I, Quintans J. Limiting dilution analysis of helper T-cell function. Immunology 1975;28:1135&#8211;48.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR26</td><td>BibArticle</td><td>Pelloquin F, Lamelin JP, Lenoir GM. Human B lymphocytes immortalization by Epstein-Barr virus in the presence of cyclosporin A. In Vitro Cell Dev Biol 1986;22:689&#8211;94.</td><td><a href=http://dx.doi.org/10.1007/BF02621085>10.1007/BF02621085</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR27</td><td>BibArticle</td><td>Parker KC, Bednarek MA, Hull LK, et al. Sequence motifs important for peptide binding to the human MHC class I molecule, HLA-A2. J Immunol 1992;149:3580&#8211;7.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR28</td><td>BibUnstructured</td><td><aug><span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Sette</span> <span style='background:#DDDDDD'>A</span></span>, <span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Buus</span> <span style='background:#DDDDDD'>S</span></span>, <span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Appella</span> <span style='background:#DDDDDD'>E</span></span>, et al.</aug> <span style='background:#CCCCFF'>Prediction of major histocompatibility complex binding regions of protein antigens by sequence pattern analysis</span>. <span style='background:#CCFF99'>Proc Natl Acad Sci USA</span> <span style='background:#66FF66'>1989</span>;<span style='background:#FFCC66'>86</span>:<span style='background:#D279FF'>3296&#8211;300</span>.</td><td><a href=http://dx.doi.org/10.1073/pnas.86.9.3296>10.1073/pnas.86.9.3296</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>Author_FamilyName_2, Year, FirstPage, VolumeID, ArticleTitle, Author_FamilyName_1</td><td>CrossRef</td></tr><tr><td>CR29</td><td>BibArticle</td><td>Stevanovic S, Jung G. Multiple sequence analysis: pool sequencing of synthetic and natural peptide libraries. Anal Biochem 1993;212:212&#8211;20.</td><td><a href=http://dx.doi.org/10.1006/abio.1993.1314>10.1006/abio.1993.1314</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR30</td><td>BibArticle</td><td>Utsugi-Kobukai S, Fujimaki H, Hotta C, Nakazawa M, Minami M. MHC class I-mediated exogenous antigen presentation by exosomes secreted from immature and mature bone marrow derived dendritic cells. Immunol Lett 2003;89:125&#8211;31.</td><td><a href=http://dx.doi.org/10.1016/S0165-2478(03)00128-7>10.1016/S0165-2478(03)00128-7</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR31</td><td>BibArticle</td><td>Lapenta C, Santini SM, Spada M, et al. IFN-alpha-conditioned dendritic cells are highly efficient in inducing cross-priming CD8(+) T cells against exogenous viral antigens. Eur J Immunol 2006;36:2046&#8211;60.</td><td><a href=http://dx.doi.org/10.1002/eji.200535579>10.1002/eji.200535579</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR32</td><td>BibArticle</td><td>Accapezzato D, Visco V, Francavilla V, et al. Chloroquine enhances human CD8+ T cell responses against soluble antigens in vivo. J Exp Med 2005;202:817&#8211;28.</td><td><a href=http://dx.doi.org/10.1084/jem.20051106>10.1084/jem.20051106</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR33</td><td>BibArticle</td><td>Hoffmann TK, Donnenberg VS, Friebe-Hoffmann U, et al. Competition of peptide-MHC class I tetrameric complexes with anti-CD3 provides evidence for specificity of peptide binding to the TCR complex. Cytometry 2000;41:321&#8211;8.</td><td><a href=http://dx.doi.org/10.1002/1097-0320(20001201)41:4&lt;321::AID-CYTO11&gt;3.0.CO;2-9>10.1002/1097-0320(20001201)41:4&lt;321::AID-CYTO11&gt;3.0.CO;2-9</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR34</td><td>BibArticle</td><td>Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 1994;179:1109&#8211;18.</td><td><a href=http://dx.doi.org/10.1084/jem.179.4.1109>10.1084/jem.179.4.1109</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR35</td><td>BibArticle</td><td>Gilleron M, Stenger S, Mazorra Z, et al. Diacylated sulfoglycolipids are novel mycobacterial antigens stimulating CD1-restricted T cells during infection with Mycobacterium tuberculosis. J Exp Med 2004;199:649&#8211;59.</td><td><a href=http://dx.doi.org/10.1084/jem.20031097>10.1084/jem.20031097</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR36</td><td>BibArticle</td><td>Russano AM, Agea E, Corazzi L, et al. Recognition of pollen-derived phosphatidyl-ethanolamine by human CD1d-restricted gamma delta T cells. J Allergy Clin Immunol 2006;117:1178&#8211;84.</td><td><a href=http://dx.doi.org/10.1016/j.jaci.2006.01.001>10.1016/j.jaci.2006.01.001</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr></table>